Results 131 to 140 of about 24,328 (140)

Phase behavior of itraconazole–phenol mixtures and its pharmaceutical applications

International Journal of Pharmaceutics, 2012
Chun-Woong Park, Heidi M Mansour, Tack-Oon Oh   +2 more
exaly  

Laponite-based nanohybrid for enhanced solubility and controlled release of itraconazole

International Journal of Pharmaceutics, 2008
Hyun Jung, Young Bin Choy, Seong-Ju Hwang   +2 more
exaly  

Antifungal Prophylaxis with Itraconazole in Prolonged Neutropenia: Correlation with Plasma Levels

Mycoses, 1989
M A Boogaerts, P Zachee, H Demuynck
exaly  

Congestive heart failure associated with itraconazole

Lancet, The, 2001
exaly  

Increased Physical Stability and Improved Dissolution Properties of Itraconazole, a Class II Drug, by Solid Dispersions that Combine Fast‐ and Slow‐Dissolving Polymers

Journal of Pharmaceutical Sciences, 2004
Geert Verreck, Jef Peeters, Guy Van Den Mooter   +2 more
exaly  

Itraconazole/TPGS/Aerosil®200 solid dispersions

European Journal of Pharmaceutical Sciences, 2009
Bernard Van Eerdenbrugh, Michiel Van Speybroeck, Raf Mols   +2 more
exaly  

Effects of gemfibrozil, itraconazole, and their combination on the pharmacokinetics and pharmacodynamics of repaglinide: potentially hazardous interaction between gemfibrozil and repaglinide

Diabetologia, 2003
Mikko Niemi, Janne T Backman, Mikko Neuvonen   +2 more
exaly  

The area under the plasma concentration-time curve for oral midazolam is 400-fold larger during treatment with itraconazole than with rifampicin

European Journal of Clinical Pharmacology, 1998
Janne T Backman, Kari T Kivisto, Klaus T Olkkola   +2 more
exaly  

Itraconazole

Reactions Weekly, 2004
openaire   +1 more source

Itraconazole

Reactions Weekly, 2015
openaire   +1 more source